Well Referenced

Tag: side effects

Subcutaneous Inflammation Mimicking Metastatic Malignancy Induced by Injection of Mistletoe Extract

This case report describes a patient who developed subcutaneous inflammation resembling metastatic malignancy after receiving mistletoe extract injections. The localized swelling and inflammation were initially mistaken for cancer progression, but a biopsy revealed that the inflammation was a reaction to the mistletoe extract itself. This case underscores the potential for

Read More »
June 26, 2025 No Comments

Summary of European Mistletoe in Cancer

​European mistletoe (Viscum album) has been used in traditional medicine for various conditions, including cancer, seizures, headaches, and menopause symptoms. In Europe, mistletoe extracts are sold as prescription drugs and are administered via injection. However, the U.S. Food and Drug Administration (FDA) has not approved mistletoe for any medical use.

Read More »
June 26, 2025 No Comments

Methylene Blue: Revisited

This systematic review evaluates the safety and efficacy of 5-aminosalicylic acid (5-ASA) for treating ulcerative colitis (UC), finding it effective in both inducing and maintaining remission in UC patients. The study showed remission rates of 50-60% depending on the dosage, with minimal side effects such as headaches and gastrointestinal disturbances.

Read More »
June 26, 2025 No Comments

Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study

​The study titled “Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study” was published in the Journal of Urology in 1998 (PMID: 9679884). This double-blind, placebo-controlled crossover study investigated the effects of Melanotan-II, a synthetic melanotropic peptide, on men with psychogenic erectile dysfunction.

Read More »
June 26, 2025 No Comments

Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II

This randomized controlled trial evaluated the effects of Melanotan II, a melanocortin receptor agonist, on penile erection and sexual desire in men with psychogenic and organic erectile dysfunction (ED). Among 20 participants, 85% experienced spontaneous penile erections without sexual stimulation, and 68% reported increased sexual desire after Melanotan II administration,

Read More »
June 26, 2025 No Comments

Systematic review and dosage analysis: hyperbaric oxygen therapy efficacy in the treatment of posttraumatic stress disorder

This systematic review evaluates the efficacy of hyperbaric oxygen therapy (HBOT) in treating posttraumatic stress disorder (PTSD), highlighting significant improvements in anxiety, depression, and hyperarousal symptoms. The studies reviewed included both military veterans and civilians with chronic PTSD, showing that HBOT at 1.5 atmospheres absolute (ATA) for 60 minutes over

Read More »
June 26, 2025 No Comments